Risk factor
Considerable default risk
Profitability factor
Favourable price performance
About
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV
Target Price
The average target price of 099190.KQ is 25850 and suggests 19% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell